Premium
Private equity firm Carlyle-controlled SeQuent Scientific Ltd. aims to establish a larger platform focussed on pure-play animal health portfolio following its recent merger announcement with active pharmaceutical ingredients (API) manufacturer Viyash Life Sciences Pvt. Ltd, VCCircle has learnt. Sequent Scientific and Viyash Life Sciences, both part of Carlyle’s portfolio, announced a ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.